(Total Views: 527)
Posted On: 08/26/2021 5:05:38 PM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
hopefully management is moving past spending time on the 13D group - i think we all should. a lot of ink being spilled - and they are a bunch of clowns, and are not our big threat. the real threat / challenge is well funded highly professional pharma companies with MABs already approved - and i can't imagine they're not all exploring other indications for their compounds.
Thus, our focus needs to be 100% about getting to market. I'd be in favor of a partnership and soon - give a little bit up to make this happen. the fact that we're sitting around and haven't even started our COVID trial is troubling - but maybe i'm the only one concerned about this.
Thus, our focus needs to be 100% about getting to market. I'd be in favor of a partnership and soon - give a little bit up to make this happen. the fact that we're sitting around and haven't even started our COVID trial is troubling - but maybe i'm the only one concerned about this.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)